Trial Profile

A Pilot Study of MDMA-Assisted Massed Exposure Therapy for PTSD (MDMA PE)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 02 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Methylenedioxymetamfetamine (Primary)
Indications Post-traumatic stress disorders
Focus Therapeutic Use

Most Recent Events

02 Sep 2024 New trial record
27 Aug 2024 According to Multidisciplinary Association for Psychedelic Studies media release, the Multidisciplinary Association for Psychedelic Studies (MAPS) awarded Emory University researchers a $200,000 grant for this pilot study

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com